CANF Started a position here at $3.60. Results for phase 2/3 psoriasis trial are due in Q1 2015. http://finance.yahoo.com/news/fite-completes-patient-enrollment-phase-110000564.html CANF ran to $8 + when positive phase 1 results were announced last Dec. Stock is currently trading near its 52 week low. Last PP was at significantly higher prices then today's $3.50 PPS. http://finance.yahoo.com/news/fite-completes-5-million-private-164400297.html Last q is here: http://finance.yahoo.com/news/fite-reports-first-quarter-2014-110000010.html